Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal's standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains.
Accepted Manuscript

Dalton Transactions
www.rsc.org/dalton
Introduction
In the fields of radiochemistry and nuclear medicine, there has been tremendous interest and global expansion in the use 89 Zr 4+ as a radionuclide (half-life: t 1/2 = 78.41 h, positron yield: β + = 22.3%) for labelling antibodies for use in immuno-positron emission tomography (Immuno-PET)
imaging. Since Perk et al. 1 and Börjesson et al. 2 reported the first clinical studies using 89 Zrradiolabelled antibodies in 2006, more than 24 clinical trials have been initiated across the world in both academia and industry, with at least 11 different 89 Zr-based agents currently under evaluation as diagnostic positron emission tomography (PET) radiotracers (source:
www.clinicaltrials.gov).
Radiolabelling species with 89 Zr 4+ ions typically involves the reaction of the hexadentate, 3 In producing 89 Zr-radiolabelled antibodies and other species, the DFO chelate can be attached to the biological vector by using various conjugation methods and linkers. 4 However, the chelate group itself remains unmodified, and in this regard, DFO has emerged as the ligand of choice for 89 Zr-radiochemistry. 3, [5] [6] [7] [8] [9] [10] [11] While an exact measure of the formation constant of the Zr-DFO complex has yet to be reported, it is likely to exceed that of Fe-DFO (log β = 30.7), and consequently, Zr-DFO has been found to display very high stability in vivo. Other chelates have also been investigated for use in complexing 89 Zr 4+ ions including polyaminocarboxylate ligands like EDTA and DTPA.
However, these alternative chelates have proven to be less stable than DFO for use in vivo. 12 Certainly, the quality of 89 Zr-mAb images generated from clinical trials supports the supposition that DFO provides an excellent ligand for Zr 4+ ions. In preclinical studies, catabolism and subsequent release of a (potentially anionic 3 ) 89 Zr-species has been found to result in modest accumulation of radioactivity in the bone in murine models. 7-9, 11, 13, 14 It should be noted that whilst bone uptake has not been observed in reported human imaging trials with 89 Zr-DFOlabelled radiotracers, this potential "instability" has, in part, provided the impetus for chemists to begin designing new ligands for 89 Zr chelation that could circumvent potential issues from undesirable irradiation of the marrow.
In 2010, Holland et al. 8 noted that Zr-complexes preferentially exhibit high coordination numbers up to 8, and density functional theory (DFT) studies on Zr-DFO revealed that the complex has the capacity to accommodate two additional water molecules as ligands in pseudoaxial and pseudo-equatorial sites. Remarkably, these calculations provide the first piece of data suggesting that water, or likely counter ions such as chloride or acetate in vivo, actively coordinate to Zr-DFO ion and in doing so increase the thermodynamic stability of the complex.
Unfortunately, a single-crystal X-ray structure of Zr-DFO remains elusive but recent studies by
Guérard et al. 15 reported the X-ray structure of 8-coordinate Zr(MeAHA) 4 
Computational Details
All calculations were conducted using density functional theory (DFT) as implemented in the Gaussian03W Revision B.04 suite of ab initio quantum chemistry programs. 16 Normal selfconsistent field (SCF) and geometry convergence criteria were employed throughout, and structures were optimised in the gas phase without the use of symmetry constraints. 44 and VSXC. 45 (iv) Hybrid meta-GGAs including TPSS1KCIS 44, 46, 47 (TPSSKCIS and (Iop(3/76=0870001300)) and BMK. 48 The origins, nomenclature and characteristics of the XC functionals studied have been described elsewhere. [49] [50] [51] Basis sets evaluated included LANL2DZ [52] [53] [54] [55] , DGDZVP 56, 57 , the Stevens/Basch/Krauss ECP basis sets [58] [59] [60] CEP-4G, CEP-31G, CEP-121G; SDDALL 52 (with default effective core potentials applied for all atoms with atomic number, Z > 2). Mixed basis set combinations were employed by evoking user-defined basis sets with the "gen" keyword. In all cases, mixed basis set combinations employed the all-electron 6-31+G(d) basis set 61, 62 for all ligand atoms with LANL2DZ (using the default LANL effective core potential for Zr), or the all-electron double-ζ "Sapporo-DZP" or triple-ζ "Sapporo-TZP" basis sets by Noro et al. 63 The effects of solvation were incorporated 64, 65 iteratively by performing self-consistent reaction field (SCRF) calculations using the integral equation formalism polarisable continuum model (IEFPCM) initially developed by Tomasi and co-workers. 66 Due to limitations in computational capacity, full geometry optimisations in the presence of the solvent field were beyond our capacity. Therefore, we used the optimised gas phase geometries as input structures for static, single point calculations incorporating the solvent reaction field. The solute-solvent boundary was defined by using a solvent excluding surface (SES). 67 The molecular solute surface was defined by using the United Atom Topological model (UAHF) for the radii of the solute atoms. 26 We used a water solvent continuum model with dielectric constant, ε = 78.39, and solvent sphere radius, R solv = 1.385 Å. The choice of solvation model reflects our standard aqueous phase conditions employed in the radiochemical synthesis of many 89 Zr-based radiotracers for positron emission tomography (PET). 3, 8, 9, 11, 13, [68] [69] [70] [71] [72] [73] Optimised structures and molecular orbitals were analysed by using Chemcraft (version 1.7, build 365).
Results and Discussion
Methodology selection
Prior to commencing mechanistic studies using density functional theory ( Next we evaluated the accuracy of various XC functionals. In total, 29 XC functionals, spanning first-and second-generation pure and hybrid generalised gradient approximation (GGA) DFT methods, through to more recent pure and hybrid meta-GGA methods were evaluated by optimising the structure of Zr(MeAHA) 4 in vacuo and comparing the calculated structures to the averaged experimental single-crystal X-ray structure (Table 2) . 15 As anticipated, the pure DFT methods provided a reasonable estimation of the Zr(MeAHA) 4 and ∆ FMO (data not shown) and are likely to be less useful in designing new ligands for Zr. We also note that due to the change in overall charge on ligand substitution, and the dominance of electrostatic interactions in solvation of these species, inclusion of the water continuum model was found to be essential for calculation of the energetics of these Zr-species.
Ligand substitution under acidic conditions
Experiments have shown that the reaction between [Zr(C 2 O 4 ) 4 ] 4-and DFO is spontaneous under neutral or even slightly acidic pH around 6. 3, 8, 14, 15 To investigate a potential role of a protonmediated mechanism of ligand substitution in the synthesis of Zr(MeAHA) 4 , we calculated the reaction pathway under simulated "acidic" conditions (noted as an approximation to pH <4).
Prior to calculating the protonated Zr-species, the energetics of proton transfer between
MeAHA and oxalic acid were investigated (Scheme 2) using the B3LYP/DGDZVP The DFT calculated acid-mediated reaction pathway for ligand exchange is presented in Scheme 3 and Figure 3 . The most prominent conclusion arising from these calculations is that (DGDZVP). We note that the non-feasibility of this acid-mediated pathway would not be circumvented by changing the starting material from 89 Zr-oxalate to, for example, 89 Zr-chloride. 3 Rather, addition of a more powerful base than C 2 O 4 2-(or chloride anions) in water is required.
These calculations are consistent with the fact that the majority of 89 Zr radiochemical reactions require the use of Na 2 CO 3 to neutralise the excess oxalic acid. Experimentally, the carbonate anions act as a proton-acceptor, driving the 89 Zr-radiolabelling reactions toward the various 89 Zrhydroxamate species via a reaction pathway akin to "basic" mechanism shown in Figure 3 . In this regard, the DFT calculations are fully consistent with experimental 89 Zr-radiolabelling reactions. The MO analysis suggests that if polarisation of charge density between the NO and carbonyl oxygen (CO) donor atoms in the didentate hydroxamate donor moiety can be increased by modifying the electronics of the backbone (methyl group) substituents, the ligand-to-metal orbital overlap and electron donation may be increased, leading to a potential further increase in the thermodynamic stability of the Zr complex. 89 Zr 4+ ions
Molecular orbital analysis of
Future design and synthesis of ligands for coordinating
Based on these calculations, it is conceivable that a design strategy toward synthesising new poly-hydroxamic acid ligands with increased stabilisation of 89 Zr 4+ ions should aim to include: 1) addition of a 4 th hydroxamic acid group to generate 8-coordinate species, 2) increased ligand flexibility, whilst maintaining preorganisation, to accommodate the increased size of the first coordination sphere from the addition of 2 donor atoms (from 6-to 8-coordinate), and 3) modification of the ligand electronics to increase the acidity/donor capabilities of the hydroxamic acid groups, potentially increasing the magnitude of "covalent-character" bonding between the ligand and 89 Zr 4+ ions. Increasing the denticity of a poly-hydroxamate ligand from 6 (as in DFO) to 8 will have the added benefit of increasing the energy stabilisation attained from increasing the magnitude of the chelate effect. In addition, DFT calculations are useful in "predicting" the thermodynamic stability of potential Zr-complexes with new ligands by calculating either full reaction pathway energetics in terms of ∆G sol / kJ mol -1 , or equally, using standalone calculations comparing the magnitude of the frontier molecular orbital energy gap, ∆ FMO / eV. Tables 1 and 2 . Figure   2 . showing the relative change in solvated free energies is presented in Figure 3 . a Calculated using the DGDZVP basis set.
Conclusion
